<p>The stack plots represent the average monthly data of costs for inpatients (A) and outpatients (B) during the preparation, intervention, and assessment periods. The costs are summarized as the costs on hospital stay (TO), medication (ME), antibiotics (AN), and very-restricted antibiotics (VR). Cross-sectional analyses were conducted by comparing the average yearly data on patents’ costs on hospital stay, medication, antibiotics, and very-restricted antibiotics (Very-Restricted) for both inpatients (C—F) and outpatients (G—I). P: preparation; I: intervention; A: assessment; *significant difference in intervention/assessment vs. preparation; <sup>#</sup>significant difference in assessment vs. intervention.</p
Pharmaceutical expenditures are an important part of the entire hospital operating budget, and inpat...
<p>Difference in average of adjusted annual cost (in euros) per patient, by number of coexisting chr...
Aims This study aimed to quantify the health economic treatment costs of clinical deterioration of ...
<p>Changes in level and slope in patients’ costs on medications (ME), antibiotics (AN), and on the v...
<p>Time series of average monthly value of the antibiotic prescribing rates (A) were plotted for inp...
<p>PBG: paper-based guidelines.ACH: average cost of hospitalization; ACM: average cost of medicine; ...
<p>In the absence of a ‘gold standard’ to estimate the economic burden of disease, a decision ...
The 28-percent change in average Medicare inpatient cost per case between 1984 and 1987 is decompose...
<p>Trends in hospital treatment cost and length of stay for mechanically ventilated (MV) patients du...
<p>Panel A shows annual HIV treatment cost as a function of site maturity. Panel B shows annual HIV ...
Antibiotic prescription habits, cost pattern, and the prospective intervention in an Intensive Care ...
[[abstract]]Motive: Control of medical expense has always been a tough issue faced by developed cou...
<p>Changes in level and slope in antibiotic prescribing rates in inpatient (RATE_I), outpatient (RAT...
The cost of drugs used in hospitals and other health care institutions is continuing to escalate, bu...
<p><b>NB:</b> Summary of mean total NHS financial cost per patient (in time specified) and mean tota...
Pharmaceutical expenditures are an important part of the entire hospital operating budget, and inpat...
<p>Difference in average of adjusted annual cost (in euros) per patient, by number of coexisting chr...
Aims This study aimed to quantify the health economic treatment costs of clinical deterioration of ...
<p>Changes in level and slope in patients’ costs on medications (ME), antibiotics (AN), and on the v...
<p>Time series of average monthly value of the antibiotic prescribing rates (A) were plotted for inp...
<p>PBG: paper-based guidelines.ACH: average cost of hospitalization; ACM: average cost of medicine; ...
<p>In the absence of a ‘gold standard’ to estimate the economic burden of disease, a decision ...
The 28-percent change in average Medicare inpatient cost per case between 1984 and 1987 is decompose...
<p>Trends in hospital treatment cost and length of stay for mechanically ventilated (MV) patients du...
<p>Panel A shows annual HIV treatment cost as a function of site maturity. Panel B shows annual HIV ...
Antibiotic prescription habits, cost pattern, and the prospective intervention in an Intensive Care ...
[[abstract]]Motive: Control of medical expense has always been a tough issue faced by developed cou...
<p>Changes in level and slope in antibiotic prescribing rates in inpatient (RATE_I), outpatient (RAT...
The cost of drugs used in hospitals and other health care institutions is continuing to escalate, bu...
<p><b>NB:</b> Summary of mean total NHS financial cost per patient (in time specified) and mean tota...
Pharmaceutical expenditures are an important part of the entire hospital operating budget, and inpat...
<p>Difference in average of adjusted annual cost (in euros) per patient, by number of coexisting chr...
Aims This study aimed to quantify the health economic treatment costs of clinical deterioration of ...